Hu X, Chen F, Jia L, Long A, Peng Y, Li X, et al. A gut-derived hormone regulates cholesterol metabolism. Cell. 2024;187(7):1685-1700.e18.

Article  CAS  PubMed  Google Scholar 

Han F, Liu X, Chen C, Liu Y, Du M, Zhou Y, et al. Hypercholesterolemia risk-associated GPR146 is an orphan G-protein coupled receptor that regulates blood cholesterol levels in humans and mice. Cell Res. 2020;30:363–5.

Article  PubMed  PubMed Central  Google Scholar 

Yu H, Rimbert A, Palmer AE, Toyohara T, Xia Y, Xia F, et al. GPR146 deficiency protects against hypercholesterolemia and atherosclerosis. Cell. 2019;179(6):1276-1288.e14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Xie Y, Chen B, Xia Y, Jiang Y, Sun Z, et al. GPR146 regulates pulmonary vascular remodeling by promoting pulmonary artery smooth muscle cell proliferation through 5-lipoxygenase. Eur J Pharmacol. 2023;961: 176123.

Article  CAS  PubMed  Google Scholar 

Kaczmarek I, Wower I, Ettig K, Kuhn CK, Kraft R, Landgraf K, et al. Identifying G protein-coupled receptors involved in adipose tissue function using the innovative RNA-seq database FATTLAS. iScience. 2023;26(10): 107841.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seidu S, Alabraba V, Davies S, Newland-Jones P, Fernando K, Bain SC, et al. SGLT2 inhibitors—the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: a narrative review. Diabetes Therapy. 2024;5(5):1099–124.

Article  Google Scholar 

Marfella R, Scisciola L, D’Onofrio N, Maiello C, Trotta MC, Sardu C, et al. Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes. Pharmacol Res. 2022;184: 106448.

Article  CAS  PubMed  Google Scholar 

D’Onofrio N, Sardu C, Trotta MC, Scisciola L, Turriziani F, Ferraraccio F, et al. Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of sodium-glucose co-transporter2 inhibitor treatment. Mol Metab. 2021;54:10133.

Google Scholar 

Clementi E, Corbi G, Boccardi V, Scisciola L. Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: data from basic science and clinical trials. Front Cardiovasc Med. 2022;9:1008922.

Article  Google Scholar 

Di Tommaso P, Chatzou M, Floden EW, Barja PP, Palumbo E, Notredame C. Nextflow enables reproducible computational workflows. Nat Biotechnol. 2017;35(4):316–9.

Article  PubMed  Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(34):15545–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;11:2498–504.

Article  Google Scholar 

Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, et al. PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008;22(21):2941–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Huang X, Yang G, Xu K, Yin Y, Brecchia G, et al. CD36 favours fat sensing and transport to govern lipid metabolism. Prog Lipid Res. 2022;88(88): 101193.

Article  CAS  PubMed  Google Scholar 

Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science (1979). 2015;347(6220).

Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19:593–606.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tinahones F, Salas J, Mayas MD, Ruiz-Villalba A, Macias-Gonzalez M, Garrido-Sanchez L, et al. VEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxigenase-2. PLoS ONE. 2009;4(12):e8213.

Article  PubMed  PubMed Central  Google Scholar 

Szekeres Z, Toth K, Szabados E. The effects of sglt2 inhibitors on lipid metabolism. Metabolites. 2021;11(2):1–9.

Article  Google Scholar 

Nagao M, Sasaki J, Tanimura-Inagaki K, Sakuma I, Sugihara H, Oikawa S. Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study. Cardiovasc Diabetol. 2024. https://doi.org/10.1186/s12933-024-02149-7.

Article  PubMed  PubMed Central  Google Scholar 

Basu D, Huggins LA, Scerbo D, Obunike J, Mullick AE, Rothenberg PL, et al. Mechanism of increased LDL and decreased triglycerides with SGLT2 inhibition HHS public access. Arterioscler Thromb Vasc Biol. 2018;38(9):2207–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji W, Zhao M, Wang M, Yan W, Liu Y, Ren S, et al. Effects of canagliflozin on weight loss in high-fat diet-induced obese mice. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0179960.

Article  PubMed  PubMed Central  Google Scholar 

Packer M. Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling/autophagy hypothesis. Circulation. 2022;146:1383–405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoong CWS, Chua MWJ. SGLT2 inhibitors as calorie restriction mimetics: insights on longevity pathways and age-related diseases. Endocrinology (United States). 2021. https://doi.org/10.1210/endocr/bqab079.

Article  Google Scholar 

Masson W, Lavalle-Cobo A, Nogueira JP. Effect of sglt2-inhibitors on epicardial adipose tissue: a meta-analysis. Cells. 2021;10:2150.

Article  PubMed  PubMed Central  Google Scholar 

Cinti F, Leccisotti L, Sorice GP, Capece U, D’Amario D, Lorusso M, et al. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovasc Diabetol. 2023. https://doi.org/10.1186/s12933-023-02091-0.

Article  PubMed  PubMed Central  Google Scholar 

Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, et al. Guidelines on the management of patients with diabetes: a position of diabetes poland. Curr Top Diabetes. 2022;2(1):1–130.

Article  Google Scholar